nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—Pindolol—HTR1B—attention deficit hyperactivity disorder	0.0116	0.647	CrCbGaD
Metoprolol—ADRB1—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0101	0.0103	CbGpPWpGaD
Metoprolol—ADRB2—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.00992	0.0101	CbGpPWpGaD
Metoprolol—ADRB1—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.00982	0.01	CbGpPWpGaD
Metoprolol—ADRB1—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.00965	0.00983	CbGpPWpGaD
Metoprolol—ADRB2—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.00961	0.00978	CbGpPWpGaD
Metoprolol—ADRB1—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.00953	0.00971	CbGpPWpGaD
Metoprolol—ADRB2—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.00944	0.00962	CbGpPWpGaD
Metoprolol—ADRB2—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.00933	0.0095	CbGpPWpGaD
Metoprolol—SLC22A2—Amine compound SLC transporters—SLC6A3—attention deficit hyperactivity disorder	0.00928	0.00945	CbGpPWpGaD
Metoprolol—ADRB1—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.00917	0.00934	CbGpPWpGaD
Metoprolol—ADRB2—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.00897	0.00913	CbGpPWpGaD
Metoprolol—ADRB1—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.00888	0.00904	CbGpPWpGaD
Metoprolol—ADRB2—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.00869	0.00885	CbGpPWpGaD
Metoprolol—ADRB1—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.00852	0.00868	CbGpPWpGaD
Metoprolol—ADRB1—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00846	0.00862	CbGpPWpGaD
Metoprolol—ADRB2—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.00834	0.00849	CbGpPWpGaD
Metoprolol—ADRB1—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00826	0.00841	CbGpPWpGaD
Metoprolol—ADRB1—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00811	0.00826	CbGpPWpGaD
Metoprolol—ADRB2—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00808	0.00822	CbGpPWpGaD
Metoprolol—ADRB1—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.00801	0.00816	CbGpPWpGaD
Metoprolol—SLC22A2—Neurotransmitter Release Cycle—SNAP25—attention deficit hyperactivity disorder	0.00796	0.0081	CbGpPWpGaD
Metoprolol—ADRB2—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00794	0.00808	CbGpPWpGaD
Metoprolol—ADRB2—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.00784	0.00798	CbGpPWpGaD
Metoprolol—ADRB1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00747	0.0076	CbGpPWpGaD
Metoprolol—ADRB2—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.0073	0.00744	CbGpPWpGaD
Metoprolol—Propranolol—HTR1B—attention deficit hyperactivity disorder	0.00634	0.353	CrCbGaD
Metoprolol—ADRB1—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.00624	0.00636	CbGpPWpGaD
Metoprolol—ADRB1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00622	0.00633	CbGpPWpGaD
Metoprolol—ADRB2—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.00611	0.00622	CbGpPWpGaD
Metoprolol—ADRB2—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00609	0.0062	CbGpPWpGaD
Metoprolol—SLC22A2—Neurotransmitter Release Cycle—MAOA—attention deficit hyperactivity disorder	0.00599	0.0061	CbGpPWpGaD
Metoprolol—SLC22A2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00558	0.00568	CbGpPWpGaD
Metoprolol—ADRB1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00523	0.00532	CbGpPWpGaD
Metoprolol—ADRB2—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00512	0.00521	CbGpPWpGaD
Metoprolol—SLC22A2—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00474	0.00483	CbGpPWpGaD
Metoprolol—CYP2C19—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00451	0.00459	CbGpPWpGaD
Metoprolol—SLC22A2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00427	0.00435	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.00427	0.00435	CbGpPWpGaD
Metoprolol—CYP2D6—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00415	0.00422	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.00414	0.00422	CbGpPWpGaD
Metoprolol—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.00363	0.0037	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00355	0.00361	CbGpPWpGaD
Metoprolol—ADRB1—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.00352	0.00358	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00347	0.00354	CbGpPWpGaD
Metoprolol—ADRB1—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00347	0.00354	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00347	0.00353	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00345	0.00351	CbGpPWpGaD
Metoprolol—ADRB2—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.00344	0.0035	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.0034	0.00346	CbGpPWpGaD
Metoprolol—ADRB2—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.0034	0.00346	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00337	0.00344	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00304	0.00309	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00298	0.00303	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00297	0.00303	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00291	0.00297	CbGpPWpGaD
Metoprolol—SLC22A2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00286	0.00291	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.0027	0.00275	CbGpPWpGaD
Metoprolol—SLC22A2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00246	0.0025	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00241	0.00245	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00241	0.00245	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00236	0.0024	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00231	0.00236	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.0023	0.00234	CbGpPWpGaD
Metoprolol—SLC22A2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00228	0.00232	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00227	0.00231	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00226	0.0023	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00222	0.00226	CbGpPWpGaD
Metoprolol—SLC22A2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00219	0.00223	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.0021	0.00214	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00206	0.0021	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00206	0.0021	CbGpPWpGaD
Metoprolol—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00204	0.00208	CbGpPWpGaD
Metoprolol—SLC22A2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00203	0.00207	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00202	0.00206	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00196	0.00199	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00195	0.00199	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00191	0.00195	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00191	0.00194	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.0019	0.00193	CbGpPWpGaD
Metoprolol—SLC22A2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00188	0.00192	CbGpPWpGaD
Metoprolol—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00188	0.00191	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00186	0.0019	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00185	0.00189	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00184	0.00187	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00182	0.00186	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.0018	0.00184	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.0018	0.00183	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00177	0.0018	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00176	0.0018	CbGpPWpGaD
Metoprolol—SLC22A2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00175	0.00178	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00173	0.00176	CbGpPWpGaD
Metoprolol—SLC22A2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00173	0.00176	CbGpPWpGaD
Metoprolol—SLC22A2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00172	0.00175	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00171	0.00175	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00168	0.00171	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00168	0.00171	CbGpPWpGaD
Metoprolol—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00165	0.00168	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00164	0.00167	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00162	0.00165	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.0016	0.00163	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00159	0.00162	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00158	0.00161	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00157	0.0016	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00156	0.00159	CbGpPWpGaD
Metoprolol—SLC22A2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00156	0.00159	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00154	0.00157	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00154	0.00157	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00147	0.0015	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00144	0.00146	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00137	0.0014	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00134	0.00137	CbGpPWpGaD
Metoprolol—SLC22A2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00133	0.00135	CbGpPWpGaD
Metoprolol—SLC22A2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00132	0.00134	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00132	0.00134	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00131	0.00133	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00128	0.0013	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00128	0.0013	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00128	0.0013	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00126	0.00128	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00125	0.00128	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00125	0.00127	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00124	0.00126	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00122	0.00124	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00121	0.00123	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.0012	0.00122	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.0012	0.00122	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00119	0.00121	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00119	0.00121	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00117	0.0012	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00117	0.0012	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00116	0.00118	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00116	0.00118	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00114	0.00116	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00112	0.00114	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00109	0.00111	CbGpPWpGaD
Metoprolol—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00109	0.00111	CbGpPWpGaD
Metoprolol—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00108	0.0011	CbGpPWpGaD
Metoprolol—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00108	0.0011	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00105	0.00106	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00103	0.00105	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00102	0.00104	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00101	0.00102	CbGpPWpGaD
Metoprolol—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.001	0.00102	CbGpPWpGaD
Metoprolol—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000998	0.00102	CbGpPWpGaD
Metoprolol—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000991	0.00101	CbGpPWpGaD
Metoprolol—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000984	0.001	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00094	0.000957	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000888	0.000904	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000869	0.000884	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000838	0.000854	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000816	0.000831	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000806	0.000821	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000799	0.000813	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000798	0.000813	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000789	0.000803	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000783	0.000798	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000776	0.00079	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000766	0.00078	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000759	0.000773	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000722	0.000735	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000706	0.000719	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000705	0.000718	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000701	0.000714	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000699	0.000712	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000689	0.000702	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000687	0.0007	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000687	0.000699	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000686	0.000699	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000684	0.000696	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000678	0.000691	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000674	0.000686	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000672	0.000685	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000672	0.000684	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000664	0.000676	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000659	0.000671	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000655	0.000667	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000641	0.000653	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000635	0.000646	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000632	0.000644	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000624	0.000635	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000621	0.000632	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000618	0.00063	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000616	0.000627	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00061	0.000621	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000603	0.000614	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000574	0.000584	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000561	0.000572	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000551	0.000561	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000551	0.000561	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000542	0.000552	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000504	0.000513	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000476	0.000485	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000466	0.000474	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000458	0.000466	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000447	0.000455	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000443	0.000451	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00044	0.000449	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000436	0.000444	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000433	0.000441	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000421	0.000428	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000419	0.000427	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000416	0.000424	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000411	0.000418	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000407	0.000415	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000402	0.000409	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000393	0.0004	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000387	0.000394	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000379	0.000386	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000375	0.000382	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000368	0.000375	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000367	0.000373	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000364	0.000371	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00036	0.000367	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000356	0.000363	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000339	0.000345	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000334	0.00034	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000332	0.000338	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000331	0.000338	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000308	0.000314	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000308	0.000314	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000303	0.000309	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000301	0.000307	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000301	0.000307	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000296	0.000302	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000284	0.000289	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000284	0.000289	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000282	0.000287	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000279	0.000284	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000275	0.00028	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000259	0.000264	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000247	0.000251	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000241	0.000245	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000237	0.000242	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000235	0.000239	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000232	0.000237	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000229	0.000233	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000227	0.000231	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000216	0.00022	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	0.000187	0.00019	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000186	0.000189	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000182	0.000186	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000181	0.000184	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.00018	0.000183	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000172	0.000175	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000171	0.000174	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—EP300—attention deficit hyperactivity disorder	0.000143	0.000146	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000126	0.000128	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000123	0.000125	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	8.01e-05	8.16e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	7.82e-05	7.96e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	7.37e-05	7.5e-05	CbGpPWpGaD
